- Stocks
- Healthcare
- NASDAQ: PGNY

Price (delayed)

$56.6

Market cap

$5.01B

P/E Ratio

85.76

Dividend/share

N/A

EPS

$0.66

Enterprise value

$4.99B

The EPS has surged by 186% year-on-year and by 22% since the previous quarter

Progyny's gross profit has surged by 58% YoY and by 18% QoQ

PGNY's quick ratio is down by 17% year-on-year and by 7% since the previous quarter

Sector: Healthcare

Industry: Health Information Services

What are the main financial stats of PGNY

Market
Valuations
Earnings

Shares outstanding

88.53M

Market cap

$5.01B

Enterprise value

$4.99B

Price to earnings (P/E)

85.76

Price to book (P/B)

26.74

Price to sales (P/S)

12.82

EV/EBIT

305.14

EV/EBITDA

274.76

EV/Sales

12.93

Revenue

$385.97M

EBIT

$16.35M

EBITDA

$18.16M

Free cash flow

$23.88M

Per share
Balance sheet
Liquidity

EPS

$0.66

Free cash flow per share

$0.27

Book value per share

$2.12

Revenue per share

$4.42

TBVPS

$3.22

Total assets

$294.59M

Total liabilities

$109.97M

Debt

$8.1M

Equity

$184.62M

Working capital

$126.8M

Debt to equity

0.04

Current ratio

2.26

Quick ratio

2.21

Net debt/EBITDA

-1.2

Margins
Efficiency
Dividend

EBITDA margin

4.7%

Gross margin

21.3%

Net margin

14.9%

Operating margin

4.2%

Return on assets

24.8%

Return on equity

38.5%

Return on invested capital

17.3%

Return on capital employed

8.4%

Return on sales

4.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Progyny stock price performed over time

Intraday

0.87%

1 week

5.52%

1 month

-5.26%

1 year

108.24%

YTD

33.52%

QTD

-4.07%

How have Progyny's revenue and profit performed over time

Revenue

$385.97M

Gross profit

$82.36M

Operating income

$16.3M

Net income

$57.57M

Gross margin

21.3%

Net margin

14.9%

Progyny's operating income has surged by 95% QoQ and by 63% YoY

PGNY's operating margin has surged by 75% since the previous quarter and by 11% year-on-year

Progyny's gross profit has surged by 58% YoY and by 18% QoQ

The revenue is up by 46% year-on-year and by 12% since the previous quarter

What is Progyny's growth rate over time

What is Progyny stock price valuation

P/E

85.76

P/B

26.74

P/S

12.82

EV/EBIT

305.14

EV/EBITDA

274.76

EV/Sales

12.93

The EPS has surged by 186% year-on-year and by 22% since the previous quarter

PGNY's equity has surged by 52% year-on-year and by 11% since the previous quarter

PGNY's price to book (P/B) is 32% higher than its last 4 quarters average of 20.3

The revenue is up by 46% year-on-year and by 12% since the previous quarter

PGNY's price to sales (P/S) is 39% higher than its last 4 quarters average of 9.2

How efficient is Progyny business performance

The company's return on equity has surged by 159% YoY and by 11% QoQ

PGNY's return on invested capital has surged by 116% year-on-year and by 18% since the previous quarter

The return on sales has surged by 68% since the previous quarter

Progyny's return on assets has increased by 9% QoQ

What is PGNY's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for PGNY.

How did Progyny financials performed over time

PGNY's total assets is 168% more than its total liabilities

PGNY's total liabilities has surged by 86% year-on-year and by 26% since the previous quarter

PGNY's total assets has soared by 64% YoY and by 16% from the previous quarter

The company's debt is 96% lower than its equity

PGNY's equity has surged by 52% year-on-year and by 11% since the previous quarter

PGNY's debt to equity is down by 20% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.